Skip to main content
UniHealth

Doctor search

Priya Jayachandran, MD

Medical Oncology · Mountain View

NPI 1962768671

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
2
1 carrier
Office
1

Offices

1 location · El Camino Health Medical Network LLC · 202 clinicians in this group

Looking this up.

Hospitals listed: El Camino Health · USC Kenneth Norris Jr Cancer Hospital. That is not proof they admit you there this week.

Plans that list them

2 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jayachandran’s office at (650) 988-8338 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
Anthem Medicare Advantage (HMO-POS)Anthem Blue CrossListedOct 3, 2026

California Medical Board record

Licence A127648 · Current

Licensed to practise in California · since 2013 · expires 2027-03-31 · University of Michigan Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at El Camino Health
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.291BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.393BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.96 (0.12 to 1.79) · 2,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.38 (125.03 to 209.73) · 96 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 68 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 185 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.8 · 200 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 814 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13 · 842 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 361 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 4,633 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 11,474 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,626 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.14 (1.39 to 4.9) · 2,814 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2 (0.61 to 3.39) · 1,327 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.8 to 3.43) · 2,641 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.39 (4.18 to 14.6) · 1,287 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.57 (3.47 to 9.68) · 1,308 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.14 (0.71 to 3.57) · 827 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.6 (0.05 to 1.15) · 9,460 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 122 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.993No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.706No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.376No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.5 · 218 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 962 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits3.8 · 200 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17 · 922 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18.6 · 860 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 827 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.1 (4.5 to 8.2) · 313 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.4 (10.6 to 16.5) · 313 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.7 · 237 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (10 to 16.1) · 1,639 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,619 casesNo differentJan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Patient survey stars by topic at El Camino Health
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at El Camino Health
Room was "always" clean75%
Nurses "always" communicated well79%
Doctors "always" communicated well81%
Staff "always" explained61%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms86%

Original Medicare doctor bills

$49,367

Medicare paid this office $49,367 for 136 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)85$32,153$113
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$3,144$98
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes19$2,934$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes19$2,061$103
Hospital discharge day management, more than 30 minutes20$2,003$95
See all 6 services
Every Original Medicare service billed
Long return visit (40+ min)85$32,153$113
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$3,144$98
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes19$2,934$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes19$2,061$103
Hospital discharge day management, more than 30 minutes20$2,003$95
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's60$1,600$14

Who their Medicare patients are

136 Original Medicare patients in 2024. Average age 74 · Under 65 12% · 85 and older 9% · Women 82% · Also on Medicaid 34% · Health risk score 2.36. Above the middle of the specialty; the typical medical oncology clinician is at 2.11.

Conditions among them: High blood pressure 75% · Cancer 75% · Diabetes 42% · Coronary heart disease 36% · Depression 32% · Chronic kidney disease 27% · COPD 18% · Atrial fibrillation 18% · Heart failure 10% · Dementia 8%.

The office billed $210,010, Medicare allowed $64,554 and paid $49,367; for 580 services of 15 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024136580742.36$210,010$49,367
2023132537732.45$233,178$56,936
202277366731.92$171,152$39,763
202138112712.02$35,562$11,349
2018150476782.71$206,702$42,615
201795351762.40$150,907$32,185

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Original Medicare services billed in 2023
Long return visit (40+ min)69$41,258$118
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes34$6,510$67
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes28$3,416$110
Hospital discharge day management, more than 30 minutes21$2,544$98

2022: 3 services

Original Medicare services billed in 2022
Long return visit (40+ min)54$31,833$123
New patient visit (60+ min)25$3,932$157
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or20$1,357$27

2021: 3 services

Original Medicare services billed in 2021
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes19$4,793$89
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes20$2,452$117
Hospital discharge day management, more than 30 minutes17$1,659$92

2018: 3 services

Original Medicare services billed in 2018
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes113$25,839$94
Hospital discharge day management, more than 30 minutes77$7,703$99
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes49$6,079$65

2017: 4 services

Original Medicare services billed in 2017
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes69$18,509$93
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes36$5,182$65
Hospital discharge day management, more than 30 minutes46$4,517$98
Initial hospital care with moderate level of medical decision making at least 75 minutes17$3,082$181

Medicaid work

$1,877 in 2021

Medicaid paid $1,877 for 49 billed services this clinician did in 2021, up to 13 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2021
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES49$1,877
Medicaid work by year
202149113$1,877
2018208222$4,340
See the largest Medicaid services in earlier years

2018

Largest Medicaid services in 2018
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES193$3,977
Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter15$363

Drugs they prescribed that Part D paid

$65,799

Pharmacies billed $65,799 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

290 generic and 11 brand-name prescriptions · $65,799 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Exemestane22$5,462$248
Anastrozole94$1,350$14
Tamoxifen Citrate43$737$17
Letrozole19$523$28
Diclofenac11$397$36
See all 6 drugs
Every Part D drug this clinician prescribed
Exemestane22$5,462$248
Anastrozole94$1,350$14
Tamoxifen Citrate43$737$17
Letrozole19$523$28
Diclofenac11$397$36
Alendronate16$218$14

Year by year

Part D prescribing by year
202430153None4%$65,799
202329844None14%$303,501
202228336NoneNone$467,358
20217826None27%$199,608
2020833215% (12)24%$210,236
20191445313% (18)19%$120,898
201814745NoneNone$13,003
20173516NoneNone$1,257

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 8 drugs

Part D drugs prescribed in 2023
Ibrance12$193,598$16,133
Exemestane24$4,100$171
Anastrozole87$2,086$24
Tamoxifen Citrate25$470$19
Alendronate19$396$21
Famotidine16$368$23
Letrozole15$341$23
Metoclopramide12$281$23

2022: 8 drugs

Part D drugs prescribed in 2022
Ibrance21$306,997$14,619
Anastrozole64$1,581$25
Exemestane11$1,197$109
Olanzapine13$1,116$86
Ondansetron17$454$27
Gabapentin11$162$15
Famotidine12$99$8
Letrozole12$40$3

2019: 1 drug

Part D drugs prescribed in 2019
Ondansetron11$200$18

2018: 2 drugs

Part D drugs prescribed in 2018
Atorvastatin11$86$8
Furosemide13$26$2

Money from drug and device companies

$29 in 2023

Industry payments by year
202311None$29
202111None$14
202077None$154
201934None$82

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Puma BiotechnologyNone$29
1 payment
  • Meals · 2023-03-13 · $29
See the published payment
Every published payment
Puma BiotechnologyMeals · 2023-03-13None$29
See earlier years (2021, 2020, 2019)

2021: $14

Payments by company in 2021
Lilly USARetevmo$14
1 payment
  • Meals for Retevmo · 2021-03-18 · $14

2020: $154

Payments by company in 2020
Blueprint MedicinesGavreto$30
1 payment
  • Meals for Gavreto · 2020-12-03 · $30
CelgeneReblozyl$23
1 payment
  • Meals for Reblozyl · 2020-05-13 · $23
IncyteJakafi$22
1 payment
  • Meals for Jakafi · 2020-05-02 · $22
AstraZeneca Pharmaceuticals LPCalquence$21
1 payment
  • Meals for Calquence · 2020-06-11 · $21
Alexion PharmaceuticalsUltomiris$20
1 payment
  • Meals for Ultomiris · 2020-05-07 · $20
Merck Sharp & DohmeNone$20
1 payment
  • Meals · 2020-02-18 · $20
Jazz PharmaceuticalsVyxeos$18
1 payment
  • Meals for Vyxeos · 2020-02-20 · $18

2019: $82

Payments by company in 2019
AmgenKanjinti$49
2 payments
  • Meals for Kanjinti · 2019-08-22 · $30
  • Meals for Kyprolis · 2019-01-17 · $19
EisaiLenvima$17
1 payment
  • Meals for Lenvima · 2019-07-30 · $17
Novartis PharmaceuticalsPromacta$16
1 payment
  • Meals for Promacta · 2019-05-28 · $16

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Janssen Research & Development, LLC · A Global, Phase 2 Study of Arx788 in Her2-Positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-Dxd · 2025Their institution$116,603
Janssen Research & Development, LLC · Ace-Breast-03 · 2024Their institution$33,834
Janssen Research & Development, LLC · Ace-Breast-O3 · 2024Their institution$12,751
Janssen Research & Development, LLC · Acebreast03 · 2024Their institution$12,247

Professional record

NPI
1962768671
Licence
CA A127648California A127648: Current · expires 2027-03-31
Trained
University of Michigan Medical School, 2012
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Medical oncology (207RX0202X); Internal medicine (207R00000X); Hospitalist (208M00000X)
Mailing address
Po Box 31309, Los Angeles, CA, 90031
NPI first listed
2012-04-06
NPI last updated
2021-12-08
NPI record certified
2021-12-08

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.